6^th World Congress on Human Genetics and Genetic Diseases April 08-09, 2019 Abu Dhabi, UAE | Radisson Blu Hotel, Abu Dhabi Yas Island

srtjyk

ysdi

I am Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, Graduate of Tehran University, School of Medicine with honor. I passed postgraduate courses on Nutrition, Gastroenterology and Hepatology, Obesity treatment and diabetes approved by Medical sciences university successfully. I am associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). I studied on fatty liver and related metabolic disorders among Iranian families from 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidemia, diabetes and nutrition as study director and clinician associate member of Hepatitis Network.

Neuroscience , Neurosurgery

Isaura Araceli has completed her studies in medicine, masters and phD in from Universidad de Guadalajara, she has been certified before the Mexican council of human genetics as a clinical geneticist. Is the director of GENERA, a company dedicated to provide corporate services of high medical specialty in the area of human genetics. She has published in reputed journals about genetics diseases, has taught at the Autonomous University of Guadalajara, where she is a research professor and member of the research committee, also has taught at the UNIVA University in master in clinical nutrition. Serves patients of genetic diseases, is voluntary in the association of patients "brothers with hemophilia" and is member of the national system of researchers.

genetic diseases

Isaura Araceli has completed her studies in medicine, masters and phD in from Universidad de Guadalajara, she has been certified before the Mexican council of human genetics as a clinical geneticist. Is the director of GENERA, a company dedicated to provide corporate services of high medical specialty in the area of human genetics. She has published in reputed journals about genetics diseases, has taught at the Autonomous University of Guadalajara, where she is a research professor and member of the research committee, also has taught at the UNIVA University in master in clinical nutrition. Serves patients of genetic diseases, is voluntary in the association of patients "brothers with hemophilia" and is member of the national system of researchers.

genetic diseases, Role of nutrition in the change of gene expression, Dysmorphology, genetic variation and diseases, Symptomatic carriers of diseases related to X-recessive

Daniel Uribe, MBA, CEO & Co Founder of Genobank.io, Serial Entrepreneur, Angel Investor,+15 years of experience in Cybersecurity, Cloud Computing; +4 years of experience in Blockchain & Bioinformatics. Recently specializes in Bioethics, Genomic & Healthcare Data. He Holds a Bs. Electronics Engineering, MBA from IPADE Business School, Executive Programs in Stanford GSB, Singularity University, Data Science at Galvanize, Digital Marketing at General Assembly & RNAseq at EcSeq Bioinformatics GmbH (Berlin).

Decentralized Privacy-preserving technologies for Genomic Data

Dr Pravin D Potdar has completed his PhD from Tata Memorial Centre, Mumbai in 1991. Last 30 years, he has been working in the field of Cellular & Molecular Biology of Cancer. Dr Potdar retired from Jaslok Hospital & Research Centre, Mumbai as a Head, Department of Molecular Medicine & Biology, after servicing there for 12years. Dr Potdar had established Molecular Diagnostics & Stem cell Research Laboratories at Jaslok and carried out various research Program in the field of Cancer Genetics and developed innovated technologies which can help to diagnose and treat various cancers. So far, Dr Potdar has published 81 papers in national & international journals. He holds position on Editorial Board of various journals. Dr Potdar’s name is included in Marquis “Who’s Who in World” Book 2012. Dr Potdar is a recipient of National Cancer Institute, USA award and also holds Faculty position at M D Anderson Cancer Centre; Houston TX, USA Presently Dr Potdar is holding the Faculty position at Dr A.P J. Abdul Kalam Research Institute, Mumbai.

Molecular profiling of cancer cells, liquid Biopsies ( Circulating Tumor Cells), Targeted Therapies & immunotherapies of cancer.

to be updated soon

Lysosomal storage disorders, Rare genetic diseases

Seyedhashem Mirmazloumi has completed his PhD at the age of 35 years from Rajiv Gandhi University of Health Sciences, Bangalore, India. He is the CEO of Aria Gene medical genetic laboratory, Qom, Iran. He has published more than 20 papers in reputed journals and has been serving as an editorial board member of repute.

Clinical Genetics . NIPT

Manohar Furtado has a PhD in protein biochemistry from Pune Universsity and completed post-deoctoral training at Northwestern University in Virology. He served on the faculty at Northwestern in the Department of Pathology and conducted basic research in Oncolgy & Infectious Diseases. He joined Applied Biosystems in 2000 and worked there as the Vice Presisident, R & D for Molecular Medicine & Applied Markets. He was a consultant for Bio-Rad, ACD, Sample 6, DxNow and Apton Biosystems. He was on the National Biodefense Science Board at DHHS (2011-2015). He is currently the CSO and CRO at Apton. He is on the Board of LexaGene

Working with super-resolution based imaging systems to enable low-cost DNA Sequencing, Genotyping and Proteomics with the goal of enabling comprehensive analysis of cellular pathway regulation, mutation load, and protein modifications. These studies will initially focus on cancer and infectious diseases related applications.

Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.

Innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity, and infectious diseases

Dr. Girish is an honored scholar of AIIMS, New Delhi and University of Rome “Tor Vergata”, Italy. He has been proactively engaged in R&D at organizations such as Policlinico “Tor Vergata” and Foundation Santa Lucia, Rome, Italy. He has served as Head, Department of Advanced Molecular Diagnostics & Cytogenetics as well as Director, R&D at Innovative Life Discoveries, India. He is extensively involved in quality initiatives and is certified ISO 15189:2012 Internal Auditor as well as Trained Inspection Team Member from College of American Pathologist. Currently, he is serving as Head, Department of Molecular Diagnostics at Diagno Labs, India since Feb 2016.

His areas of Interest are Molecular Oncology. He is an active member of various National and International Groups in the field of Molecular Pathology, Oncology and Infectious Diseases.